No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:172966000-172968800 |
Flanking Bivalent TSS/Enh |
Monocytes-CD14+_RO01746 |
blood
|
2 |
chr2:172966200-172968800 |
Flanking Bivalent TSS/Enh |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
3 |
chr2:172967000-172968800 |
Active TSS |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
4 |
chr2:172967400-172968800 |
Active TSS |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
5 |
chr2:172967400-172969000 |
Active TSS |
Brain Germinal Matrix |
brain
|
6 |
chr2:172967600-172968800 |
Flanking Active TSS |
Dnd41 |
blood
|
7 |
chr2:172967800-172968800 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
8 |
chr2:172967800-172968800 |
Flanking Active TSS |
K562 |
blood
|
9 |
chr2:172967800-172968800 |
Flanking Active TSS |
NHEK |
skin
|
10 |
chr2:172968000-172969000 |
Bivalent Enhancer |
Fetal Intestine Small |
intestine
|
11 |
chr2:172968000-172969000 |
Bivalent Enhancer |
Placenta |
Placenta
|
12 |
chr2:172968000-172969000 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
13 |
chr2:172968000-172969200 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
14 |
chr2:172968000-172969200 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
15 |
chr2:172968000-172970600 |
Weak transcription |
Pancreas |
Pancrea
|
16 |
chr2:172968000-172974800 |
Weak transcription |
Gastric |
stomach
|
17 |
chr2:172968200-172968800 |
Bivalent Enhancer |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
18 |
chr2:172968200-172968800 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
19 |
chr2:172968200-172968800 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
20 |
chr2:172968200-172968800 |
Flanking Active TSS |
A549 |
lung
|
21 |
chr2:172968200-172969000 |
Bivalent Enhancer |
Primary T helper naive cells fromperipheralblood |
blood
|
22 |
chr2:172968200-172969000 |
Bivalent Enhancer |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
23 |
chr2:172968200-172969000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
24 |
chr2:172968200-172969200 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
25 |
chr2:172968200-172969200 |
Bivalent Enhancer |
Primary T helper memory cells from peripheral blood 2 |
blood
|
26 |
chr2:172968200-172969200 |
Bivalent Enhancer |
Primary T helper memory cells from peripheral blood 1 |
blood
|
27 |
chr2:172968200-172969200 |
Bivalent Enhancer |
Primary T helper 17 cells PMA-I stimulated |
--
|
28 |
chr2:172968200-172969200 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
29 |
chr2:172968200-172969200 |
Bivalent Enhancer |
Primary T killer naive cells fromperipheralblood |
blood
|
30 |
chr2:172968200-172969200 |
Bivalent Enhancer |
Primary T killer memory cells from peripheral blood |
blood
|
31 |
chr2:172968200-172969400 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
32 |
chr2:172968200-172970400 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
33 |
chr2:172968200-172970400 |
Weak transcription |
HSMM |
muscle
|
34 |
chr2:172968200-172971000 |
Weak transcription |
Right Atrium |
heart
|
35 |
chr2:172968200-172971200 |
Bivalent Enhancer |
Fetal Thymus |
thymus
|
36 |
chr2:172968400-172968800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
37 |
chr2:172968400-172968800 |
Flanking Bivalent TSS/Enh |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
38 |
chr2:172968400-172968800 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
39 |
chr2:172968400-172968800 |
Bivalent Enhancer |
Placenta Amnion |
Placenta Amnion
|
40 |
chr2:172968400-172969000 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
41 |
chr2:172968400-172969000 |
Bivalent Enhancer |
Duodenum Mucosa |
Duodenum
|
42 |
chr2:172968400-172969200 |
Bivalent Enhancer |
Primary T helper cells PMA-I stimulated |
--
|
43 |
chr2:172968400-172969200 |
Bivalent Enhancer |
Primary T regulatory cells fromperipheralblood |
blood
|
44 |
chr2:172968400-172969200 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
45 |
chr2:172968400-172969200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
46 |
chr2:172968400-172970200 |
Weak transcription |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
47 |
chr2:172968400-172970200 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
48 |
chr2:172968400-172970800 |
Weak transcription |
HMEC |
breast
|
49 |
chr2:172968600-172968800 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
50 |
chr2:172968600-172968800 |
Flanking Bivalent TSS/Enh |
Primary neutrophils fromperipheralblood |
blood
|